Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Research & Development (2016 - 2025)

Historic Research & Development for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to $193000.0.

  • Biomerica's Research & Development fell 2490.27% to $193000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $874000.0, marking a year-over-year decrease of 2478.49%. This contributed to the annual value of $1.0 million for FY2025, which is 3138.83% down from last year.
  • Biomerica's Research & Development amounted to $193000.0 in Q4 2025, which was down 2490.27% from $212000.0 recorded in Q3 2025.
  • Biomerica's Research & Development's 5-year high stood at $564000.0 during Q1 2021, with a 5-year trough of $193000.0 in Q4 2025.
  • Moreover, its 5-year median value for Research & Development was $365000.0 (2022), whereas its average is $359126.6.
  • Per our database at Business Quant, Biomerica's Research & Development plummeted by 5578.35% in 2021 and then soared by 6367.53% in 2022.
  • Biomerica's Research & Development (Quarter) stood at $548000.0 in 2021, then decreased by 15.69% to $462000.0 in 2022, then fell by 10.82% to $412000.0 in 2023, then crashed by 37.62% to $257000.0 in 2024, then fell by 24.9% to $193000.0 in 2025.
  • Its Research & Development was $193000.0 in Q4 2025, compared to $212000.0 in Q3 2025 and $252000.0 in Q2 2025.